Which statement best distinguishes TLI and PLI in clinical use?

Which statement best distinguishes TLI and PLI in clinical use?

• A. TLI diagnoses exocrine pancreatic insufficiency; PLI diagnoses pancreatitis
• B. TLI diagnoses pancreatitis; PLI diagnoses exocrine pancreatic insufficiency
• C. TLI diagnoses liver disease; PLI diagnoses kidney disease
• D. Both TLI and PLI diagnose pancreatitis

Answer: (A)

The main idea is that these two tests measure different pancreatic functions and are used for different diseases. TLI (trypsin-like immunoreactivity) reflects the pancreas’s ability to produce digestive enzymes; when exocrine pancreatic insufficiency is present, TLI falls, so a low TLI supports a diagnosis of EPI. PLI (pancreatic lipase immunoreactivity) reflects pancreatic inflammation; elevated PLI indicates pancreatitis, making it the test of choice to diagnose pancreatitis rather than EPI. Therefore, the statement that TLI is for diagnosing exocrine pancreatic insufficiency and PLI is for pancreatitis best captures their distinct clinical roles. The other options mix these associations—TLI does not diagnose pancreatitis, and PLI is not used to diagnose EPI—so they fit less well.

The main idea is that these two tests measure different pancreatic functions and are used for different diseases. TLI (trypsin-like immunoreactivity) reflects the pancreas’s ability to produce digestive enzymes; when exocrine pancreatic insufficiency is present, TLI falls, so a low TLI supports a diagnosis of EPI. PLI (pancreatic lipase immunoreactivity) reflects pancreatic inflammation; elevated PLI indicates pancreatitis, making it the test of choice to diagnose pancreatitis rather than EPI. Therefore, the statement that TLI is for diagnosing exocrine pancreatic insufficiency and PLI is for pancreatitis best captures their distinct clinical roles. The other options mix these associations—TLI does not diagnose pancreatitis, and PLI is not used to diagnose EPI—so they fit less well.